Glucosylceramide synthase — Drug Target

All drugs that target Glucosylceramide synthase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Glucosylceramide synthase inhibitor

Marketed (1)

• Miglustat (Zavesca) · University of Washington · Glucosylceramide synthase inhibitor · Rare genetic/lysosomal storage diseases
  Miglustat inhibits glucosylceramide synthase, reducing the accumulation of glucosylceramide and related glycosphingolipids in cells.